{
    "2021-04-07": [
        [
            {
                "time": "2021-04-07",
                "original_text": "午间公告2021年4月7日星期三 贝达药业：1类抗癌新药BPI-421286获批临床",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "BPI-421286",
                        "抗癌新药",
                        "临床试验批准"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-07",
                "original_text": "贝达药业拟H股上市 新药能否接棒化解大单品增长隐忧？",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "H股上市",
                        "新药",
                        "增长隐忧"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "mixed"
                }
            },
            {
                "time": "2021-04-07",
                "original_text": "【贝达药业*朱国广】深度：以运营战略巩固城池，用创新实力开疆拓土",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "运营战略",
                        "创新实力"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-07",
                "original_text": "【东吴晨报0407】【策略】【宏观】【行业】机械、电子【个股】通威股份、爱婴室、华菱钢铁、贝达药业",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "个股分析",
                        "机械",
                        "电子"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "机械",
                        "电子"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}